Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer
about
Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathologyEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentRapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.CA125 in ovarian cancerInhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulationTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesCharacterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.TGFβ in T cell biology and tumor immunity: Angel or devil?Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.Dendritic cell activation by glucan isolated from umbilicaria esculentaMelatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives.Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell linesWhat can ecology teach us about cancer?Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.Bone-immune cell crosstalk: bone diseases.NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model.MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor releaseProthymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Harnessing DNA-induced immune responses for improving cancer vaccines.Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro.Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host diseaseIs interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cellsDown-regulation of PLCγ2-β-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer.Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrowIntravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.Adoptive immunotherapy: good habits instilled at youth have long-term benefits.Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells.Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced toleranceTumor microenvironment and myeloid-derived suppressor cells.Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.Myeloid-derived suppressor cells in immunity and autoimmunity.Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells.
P2860
Q26825075-9D655118-737C-4851-92A9-ED9D28BB2846Q26862642-7D34823F-033E-4E5E-B633-555D8B5EA403Q28241308-541E0058-E650-447C-A0D3-F686EDF5F616Q33738154-C383890C-F9CB-4C4F-BC02-4ED245D92F63Q33859857-B05E4619-D51E-4C6F-A9EF-E557290A0013Q34027988-62512C72-B9AA-4FA1-9ADD-A654DEF6CF70Q34044797-E2E81229-8ABB-4EAA-A9A3-185FC3166781Q34072679-00A693E0-F4C5-4DBA-89FB-9F8552BC779EQ34276027-20DE8753-22E4-423A-9D55-77B9543280ECQ34321844-F4161FC3-AE5E-4A70-A3F2-57E2BAD7BD28Q34502899-60F1CB36-5D9F-4832-936B-4F2D016D96C3Q34521014-3AF45E3E-A392-43BD-B34E-49D95BCD2141Q34994700-AB14B23C-63D3-4879-9209-F86EE5FA1138Q35082018-E5C6A722-CE8E-4A57-AD0B-42912D226C4DQ35182579-C05A149E-B74D-4B77-AE91-F1160CAF4902Q35345202-D29CBDD6-C1A7-4F56-9AA0-3F20AC62C227Q35592362-5A538589-61BD-4F6B-B34B-F503270E55D1Q35608731-BEE4249D-6502-46DC-858E-FA9E1BBFD964Q35748965-163DDEC6-91B7-4224-9CDC-3AD7EEEF001EQ35981563-95E62CC7-D96D-4B06-A2D1-16B4B5BD2FD9Q36054193-4BD04EB9-3423-4257-9051-7150EB0D94A0Q36476085-DED4CEB1-D340-4E2F-83E5-21DFDA2D3C1AQ36489379-94E0C973-D2EC-4A76-A202-448078BB9A55Q36694866-363BD76E-FE8A-4B64-AA07-9BBC95E06809Q36907662-9A9D4E99-BDE4-481F-BECC-1644EB9FB296Q37062216-05596FEE-3D14-4E72-9E15-944821AEB519Q37094951-07B12E8E-962E-4F1C-B4ED-F3BCC598EC0FQ37118170-36633897-3FD8-46BE-B35A-2E7CD1182715Q37238430-55E10FCF-A24F-42B1-A729-C2FC3D720293Q37246466-4DF227E3-893D-4075-A903-437AB86608C6Q37249025-612A592B-3103-4884-AF79-6E520BB75FA2Q37254863-A1552F31-C59D-4FF5-A0D7-1E934FB504B4Q37257225-DB4BD54F-4836-45B5-8610-EC960C2B65FCQ37291308-2D5910D7-442A-4DF9-9B04-EAD2C97D8CB2Q37856017-C843928F-A394-471C-933B-3BCC7C648C32Q37959968-94532BD3-AFAB-4538-9193-B3542C76ADB2Q38067642-E9B66516-45E0-4F18-BFDC-CD46541D87D4Q38096466-D42C1782-37CF-43FD-AF98-7CED836F96CCQ38509763-15A44343-67F5-413E-8FD5-B078C3A85575Q38526464-8C3C2C46-178E-45EB-9737-172E569A96FE
P2860
Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@ast
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@en
type
label
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@ast
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@en
prefLabel
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@ast
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@en
P2860
P1476
Effect of tumor-derived cytoki ...... res of myeloid cells in cancer
@en
P2093
Dmitry I Gabrilovich
P2860
P2888
P304
P356
10.1007/S10555-006-9002-6
P50
P577
2006-09-01T00:00:00Z